Highly Active Antiretroviral Therapy Clinical Trials Highly Active Antiretroviral Therapy RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

An Enhanced Adherence Support Programme for Highly Active Antiretroviral Therapy (HAART)
Condition:   HIV InfectionsInterventions:   Behavioral: Enhanced adherence support;   Behavioral: Standard adherence supportSponsors:   Centre for the AIDS Programme of Research in South Africa;   Doris Duke Charitable FoundationCompleted - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 6, 2006 Category: Research Source Type: clinical trials

Safety, Tolerability and Immune Response to LC002, an Experimental Therapeutic Vaccine, in Adults Receiving HAART
Condition:   HIV InfectionsInterventions:   Biological: LC002 standard vaccination;   Biological: LC002 high-dose vaccination;   Biological: LC002 placebo vaccinationSponsors:   National Institute of Allergy and Infectious Diseases (NIAID);   AIDS Clinical Trials GroupCompleted - verified March 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 21, 2005 Category: Research Source Type: clinical trials

Chemotherapy and HAART to Treat AIDS-related Primary Brain Lymphoma
Conditions:   Lymphoma-AIDS-Related;   Brain NeoplasmInterventions:   Drug: Methotrexate;   Drug: Rituximab;   Drug: LeucovorinSponsor:   National Cancer Institute (NCI)Recruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 21, 2005 Category: Research Source Type: clinical trials